Search

everythinglearnresearchcommunity

for

Search:↓

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

Fever and rash can be early signs of lupus.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

Blood pressure drugs can cause skin lupus, early treatment is key for baby herpes and diabetic foot ulcers, a certain vaccine works against genital herpes and HPV in women, more frequent light therapy helps psoriasis, smoking and drinking can worsen psoriasis, a cream clears up a type of skin cancer, and low iron levels don't cause chronic hair loss.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.

Women with pattern hair loss often have higher blood sugar, cholesterol, blood pressure, and waist size, suggesting a link between hair loss and metabolic syndrome.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Lupus can cause hair loss and nail changes, with treatments available for both.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

COVID-19 can cause or worsen skin conditions and might show early signs of infection.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

There's no significant link between hair loss from male pattern baldness and early heart disease.